Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma.
Rebecca Jane LeeGarima KhandelwalFranziska BaenkeAlessio CannistraciKenneth MacleodPiyushkumar MundraGarry AshtonAmit MandalAmaya VirosGabriela GremelElena GalvaniMatthew SmithNeil CarragherNathalie DhomenCrispin MillerPaul LoriganRichard MaraisPublished in: ESMO open (2021)
Heterogeneous tumour interactions within the brain microenvironment enable progression on immune and targeted therapies and should be targeted in salvage treatments.